Screening Patients for Elevated Left Ventricular End-Diastolic Pressure Using a Novel Noninvasive Brachial Cuff-ECG...

Area of Science:

• Cardiology
• Medical Devices
• Diagnostic Technology

Background:

• Left ventricular end-diastolic pressure (LVEDP) measurement is crucial for heart failure diagnosis but requires invasive procedures.
• Developing a noninvasive method for LVEDP assessment can significantly enhance heart failure detection.
• This study validates a novel noninvasive system for identifying elevated LVEDP.

Purpose of the Study:

• To validate the accuracy of the Vivio System, a noninvasive tool, in detecting elevated LVEDP.
• To assess the system's performance across a multicenter study population.
• To determine the potential of the Vivio System in improving early heart failure diagnosis.

Main Methods:

• The Vivio System utilizes a modified blood pressure cuff and single-lead ECG to analyze brachial artery waveforms.
• A predictive model was developed to identify patients with LVEDP exceeding 18 mm Hg.
• The study involved an invasive cohort undergoing cardiac catheterization and a control group, with data split into training and validation sets.

Main Results:

• Leave-one-out cross-validation on the training set showed a sensitivity of 0.84 and specificity of 0.84.
• The validation dataset demonstrated a sensitivity of 0.80 and specificity of 0.83 for detecting elevated LVEDP.
• These results indicate consistent performance in identifying patients with elevated LVEDP.

Conclusions:

• The Vivio System demonstrates significant accuracy in detecting elevated LVEDP.
• This noninvasive approach holds promise for improving the early diagnosis of heart failure.
• The system has the potential to revolutionize heart failure management in outpatient environments.